Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.4.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BH.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BS.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.13.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JU.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.161NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.75NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
B.1.411NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.217NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.17 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.626NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.629NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.61 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.75.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.524NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.79.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.55NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used